Aging and hypertension decrease endothelial NO-related dilating function and gamma-glutamyl transferase activity but not S-nitrosoglutathione-induced aortic vasodilation

Fundam Clin Pharmacol. 2018 Apr;32(2):134-140. doi: 10.1111/fcp.12347. Epub 2018 Feb 1.

Abstract

S-nitrosoglutathione (GSNO), which is involved in the transport and the storage of NO, induces vasorelaxation. It requires gamma-glutamyl transferase (GGT), an enzyme present on the endothelium, to transfer NO into the cell. We evaluated whether aging and hypertension, which induce NO-related dilating dysfunction, are associated with decreased vascular GGT activity and modify the vasorelaxant effect of GSNO. Thoracic aortic rings isolated from male spontaneous hypertensive rats (SHR) and Wistar-Kyoto rats (WKY) aged 20-22 (adult) or 57-60 weeks (mature) were preconstricted with phenylephrine, then submitted to concentration-vasorelaxant response curves (maximal response: Emax ; pD2 ) to GSNO and carbachol (the latter to measure NO-related dilating function). GGT activity was measured using chromogenic substrate. Both aging and hypertension lowered Emax values for carbachol (Emax -8% in adult SHR, -42% in mature SHR vs. age-matched WKY, page and phypertension < 0.05) demonstrating NO-related dilating dysfunction. Aortic GGT activity also decreased with aging and hypertension (-22% in adult and -75%, reaching 3 nmol/min/g of tissue, in mature SHR vs. 12 in age-matched WKY and 23 in adult WKY, page and phypertension < 0.05). The pD2 values of GSNO were similar in mature SHR and WKY but higher in adult SHR (pinteraction < 0.05). Aging in hypertensive rats decreased NO-related vasorelaxant function and vascular GGT activity, but did not lower the vasorelaxant response to GSNO. This opens perspectives for GSNO-based therapeutics restoring nitric oxide bioavailability and vascular protection in a context of endothelial dysfunction.

Keywords: NO-dependent vasorelaxation; S-nitrosoglutathione; gamma-glutamyltransferase; spontaneous hypertensive rat.

MeSH terms

  • Age Factors
  • Aging*
  • Animals
  • Antihypertensive Agents / pharmacology
  • Aorta, Thoracic / drug effects
  • Aorta, Thoracic / enzymology*
  • Aorta, Thoracic / physiopathology
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / enzymology*
  • Endothelium, Vascular / physiopathology
  • Glutathione / analogs & derivatives*
  • Glutathione / metabolism
  • Glutathione / pharmacology
  • Hypertension / drug therapy
  • Hypertension / enzymology*
  • Hypertension / physiopathology
  • Male
  • Nitric Oxide / metabolism*
  • Nitro Compounds / metabolism*
  • Nitro Compounds / pharmacology
  • Rats, Inbred SHR
  • Rats, Inbred WKY
  • Signal Transduction
  • Vasodilation* / drug effects
  • Vasodilator Agents / pharmacology
  • gamma-Glutamyltransferase / metabolism*

Substances

  • Antihypertensive Agents
  • Nitro Compounds
  • S-nitroglutathione
  • Vasodilator Agents
  • Nitric Oxide
  • gamma-Glutamyltransferase
  • Glutathione